Frank Meiss

12PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEthical use of new technologyHaematological tumoursMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 22, 2025
Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centers.

Markus Reitmajer, Elisabeth Livingstone, Lucie Heinzerling

|Jan 03, 2025
Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanoma.

Markus Reitmajer, Elisabeth Livingstone, Kai-Martin Thoms

|Dec 20, 2024
Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1<sup>+</sup>CD8<sup>+</sup> T cells.

Zhen Zhang, Marlene Langenbach, Sagar Sagar

|Sep 12, 2024
Second opinion and self-efficacy in German skin cancer patients.

Henner Stege, Sara Schneider, Andrea Forschner

|Jan 26, 2024
Epidermolysis-Bullosa-Associated Squamous Cell Carcinomas Support an Immunosuppressive Tumor Microenvironment: Prospects for Immunotherapy.

David Rafei-Shamsabadi, Lena Scholten, Sisi Lu

|Jul 27, 2022
eHealth Literacy in German Skin Cancer Patients.

Henner Stege, Sara Schneider, Andrea Forschner

Pageof 2

Frequent Collaborators

4 joint publications

Andrea Forschner

3 joint publications

David Rafei-Shamsabadi

2 joint publications

Maximilian Haist

2 joint publications

Markus Reitmajer